BHE

Benchmark is a contract manufacturer (EMS + precision machining) whose 2025 results disqualify the current $91.88 quote. Revenue was flat at $2.75B, but operating income fell 30.5% to $76M and net income collapsed 59.3% to $24.9M, dragging net margin to 0.9% from 2.4% and ROE to 2.3%. The MD&A pinpoints why: restructuring charges and other costs jumped from 0.3% to 1.1% of sales, SG&A crept from 5.6% to 6.0%, and the income-tax line nearly doubled to 1.4% of sales. Gross margin sat at 10.2% — this is a thin-margin business by design, with no real operating leverage to lean on when mix turns.

The top-line mix is the second yellow flag. AC&C revenue fell 27% in 2025, masking gains in A&D (+19%) and Medical (+7%). Customer concentration is severe and getting more so — top 10 customers are 51% of sales and Applied Materials alone is 14% in both 2025 and 2024. Management's own risk language flags 'customer demand fluctuations, supply chain constraints, continuing inflationary pressures … tariffs and retaliatory countermeasures' and the 'ability to utilize the Company's manufacturing facilities at sufficient levels to cover its fixed operating costs' — which is exactly what under-absorbed FY2025 already showed. Operating cash flow fell 34.5% to $124M while capex rose 14% to $35.6M.